MDWD
What one share of Mediwound holds
Medicinal Chemicals and Botanical Products
We are a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Our solutions selectively remove non-viable hazardous tissue while preserving healthy tissue, offering a safer and more effective alternative to traditional methods.
Mediwound’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $1.49 |
|---|---|
| Profit | −$2.10 |
| Capex (buildings and equipment) | $0.48 |
| Free cash flow | −$1.90 |
| Cash and investments | $0.37 |
| Book value | $3.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $0.03 | −$1.02 | $0.02 | −$0.92 | — | $1.08 |
| 2016 | $0.07 | −$0.86 | $0.03 | −$0.78 | — | $0.35 |
| 2017 | $0.11 | −$0.95 | $0.04 | −$0.75 | — | $0.35 |
| 2018 | $0.13 | −$0.04 | $0.02 | −$0.47 | — | $0.33 |
| 2019 | $1.17 | $0.18 | $0.03 | $0.28 | — | $0.56 |
| 2021 | $6.11 | −$3.48 | $0.13 | −$2.42 | — | −$1.18 |
| 2022 | $5.31 | −$3.93 | $0.11 | −$2.49 | — | $1.51 |
| 2023 | $2.07 | −$0.75 | $0.72 | −$1.88 | — | $3.43 |
| 2024 | $2.03 | −$3.03 | $0.63 | −$2.00 | — | $2.89 |
| 2025 | $1.49 | −$2.10 | $0.48 | −$1.90 | — | $3.40 |